Weiling He | Cancer Genomics Computational Studies | Best Researcher Award

Published on by Computational Biologists

Prof. Weiling He | Cancer Genomics Computational Studies | Best Researcher Award

Professor at Xiamen University, China

Dr. Weiling He is a leading figure in precision oncology, serving as Chief Physician, Professor, Doctoral and Postdoctoral Supervisor, and President of Xiang’an Hospital at Xiamen University. He is widely recognized for his contributions to cancer treatment, particularly in the domains of tumor microenvironments and drug resistance. Honored with the National Natural Science Foundation of China’s Excellent Young Scientist Fund and recognized as a Distinguished Young Medical Talent of Guangdong Province, Dr. He has established himself as a trailblazer in translational medical research. His prolific output includes over 50 SCI-indexed publications and six granted patents, underscoring his influence in both academia and clinical application.

Profile

Scopus

Education

Dr. He holds both an MD and a PhD, equipping him with a robust foundation for navigating the complex landscape of cancer research and treatment. His academic journey reflects a commitment to scientific excellence and multidisciplinary learning, enabling him to bridge the gap between theoretical research and clinical practice. The integration of medicine and scientific inquiry during his training shaped his ongoing work in precision medicine, translational oncology, and systems biology.

Experience

With a career marked by leadership and innovation, Dr. He currently serves as the President of Xiang’an Hospital at Xiamen University. He has led more than 20 research projects at the national and provincial levels, including prestigious programs under the National Key R&D Initiative and the National Natural Science Foundation of China. Dr. He has also contributed extensively to industry-academia collaboration, participating in strategic projects like the Guangdong Soft Science Program and the Guangzhou Future Industry Initiative. His academic affiliations include leadership roles in over ten national medical associations, reflecting a deep engagement with both clinical and academic ecosystems.

Research Interest

Dr. He’s research focuses on unraveling the mechanisms of tumor drug resistance, exploring metastasis pathways, and analyzing the tumor microenvironment. He is particularly interested in precision interventional therapy and the development of biomaterials and microfluidic technologies for real-time monitoring and treatment. His interdisciplinary approach combines oncology, engineering, and systems biology to improve the outcomes of metastatic cancer therapies. Through collaborative research with institutions such as Sun Yat-sen University and Emory University, he advances new methodologies in clinical translation and integrative cancer treatment.

Award

Dr. Weiling He has received several distinguished honors throughout his career. Among them, the National Natural Science Foundation of China awarded him the Excellent Young Scientist Fund, recognizing his outstanding potential and research impact in oncology. In addition, he was named a Distinguished Young Medical Talent of Guangdong Province, affirming his influence on medical innovation and leadership. His work is frequently acknowledged in national and international forums, and he has played a pivotal role in advancing precision medicine initiatives across China.

Publication

Dr. He has authored more than 50 papers indexed in SCI journals, with several appearing in top-tier publications. Notable recent works include:

“Immune Microenvironment Remodeling in Colorectal Cancer,” Cancer Immunology Research, 2020 – cited 326 times.

“Dual Nanoparticle Delivery in Precision Oncology,” Advanced Science, 2021.

“Microfluidic Chips for Real-time Tumor Monitoring,” Nature Communications, 2022.

“Translational Biomaterials in Interventional Therapy,” Science Translational Medicine, 2023 (cover article).

“Integrated Oncology Systems for Drug Resistance,” Nature Cancer, 2023.

“Microsphere Technology for Metastatic Cancer,” Advanced Science, 2024.

“Tumor Sensitization Targets for Interventional Therapy,” Nature Communications, 2024.

These publications have garnered over 1000 citations in total, with multiple works recognized as “Highly Cited Papers” in their respective fields.

Conclusion

Dr. Weiling He’s exceptional academic record, impactful research, numerous high-impact publications, robust patent portfolio, and her pivotal role in the advancement of precision oncology mark her as a standout candidate for the Best Researcher Award. Her commitment to interdisciplinary innovation and translational impact makes her not only deserving of this honor but a role model for future generations in computational and medical biology.

Gayatri Iyer | Pharmacogenomics | Best Researcher Award

Published on by Computational Biologists

Dr. Gayatri Iyer | Pharmacogenomics | Best Researcher Award

Scientist III at Tata Institute for Genetics and Society, India

Dr. Gayatri R. Iyer is a leading clinical geneticist and molecular biologist specializing in genetic counseling and rare disease diagnostics. With over a decade of hands-on experience in both research and clinical genetics, she bridges molecular science with patient-centric healthcare. She currently serves as Scientist Grade II at the Tata Institute for Genetics and Society, where she develops cost-effective diagnostic solutions for complex genetic disorders. Certified at Level II by the Board of Genetic Counseling, India, and holding an INSPIRE fellowship from the Department of Science and Technology, her professional journey reflects excellence in research, diagnostics, and community outreach. Her multidisciplinary expertise and contributions make her a standout nominee in the field of translational genetics.

profile

google scholar

Education

Dr. Iyer’s academic foundation is built on a rigorous and multidisciplinary path. She earned her Ph.D. in Human Genetics from Kamineni Hospitals, affiliated with Osmania University, where she was a DST-INSPIRE Fellow (2016–2021). Her doctoral research focused on developing methylation-specific PCR assays for imprinting disorders, reflecting her dedication to translating molecular diagnostics into clinical practice. She completed her M.Sc. in Applied Genetics from The Oxford College of Science, Bangalore, with a gold medal for academic excellence (2012–2014), and secured second rank in her B.Sc. in Biotechnology from Birla College, Mumbai (2012). She has supplemented her academic training with a PG Certificate in Medical & Genetic Counseling and a diploma in Bioinformatics.

Experience

With progressive experience in clinical genetics, Dr. Iyer has held diverse roles across premier institutions. At the Tata Institute for Genetics and Society (2023–present), she focuses on developing diagnostic platforms for rare disorders such as imprinting syndromes and neuromuscular conditions. During her postdoctoral fellowship at IIT Bombay (2022–2023), she worked on subcellular proteomics and gut microbiome sequencing. At Kamineni Hospitals, Hyderabad (2015–2021), she evolved from a Junior to Senior Research Fellow and served as a senior genetic counselor, managing over 2,000 cases across specialties including pediatrics, oncology, and reproductive medicine. Her work at LifeCell International and Datar Genetics further solidified her position as an expert counselor and educator.

Research Interest

Dr. Iyer’s research is centered on rare genetic diseases, molecular diagnostics, pharmacogenomics, and genetic counseling. She is especially focused on developing accessible and cost-effective diagnostic tools for Indian and resource-limited populations. Her doctoral work on imprinting disorders was groundbreaking, contributing novel diagnostic pathways for syndromes like Prader-Willi and Angelman. She is equally invested in epigenetics, next-generation sequencing, and microarray-based diagnostics. Her translational approach ensures that molecular insights are effectively integrated into patient care, family screening, and policy development. She continues to bridge the gap between lab-based discoveries and real-world clinical applications through genetic counseling and education.

Awards

Dr. Iyer’s contributions have been consistently recognized at national and international levels. She is the recipient of the DST Faculty Research Grant (2024–2029) and co-investigator on an ICMR CAR grant. Her global reputation was affirmed by receiving a $3,500 workshop grant and a travel grant from the International Prader-Willi Syndrome Organization. She was awarded the prestigious DST-INSPIRE Fellowship (2016–2021) and secured a travel grant to present her research at the Asia Pacific Prader-Willi Conference in Brisbane (2018). Her academic accolades include the Gold Medal in M.Sc. Applied Genetics and first rank in her Bioinformatics diploma. She also serves as Joint Secretary of the Executive Committee, Board of Genetic Counseling, India.

Publications

Dr. Iyer has contributed to over 15 peer-reviewed journal articles and book chapters. Selected impactful publications include:

Halder A, Iyer G, et al. (2023). Targeted proteomics distinguishes high and low grade meningioma tumors. Clin Proteomics, 20(1):41. [Cited by: 5]

Bajaj S, Iyer G, et al. (2022). Telegenetics diagnosis of Hunter syndrome during COVID-19. Int J Contemp Pediatr, 9:851–4. [Cited by: 2]

Iyer GR, et al. (2022). NGS in musculoskeletal disorders. J Orthop Surg Res, 17(1):76. [Cited by: 3]

Iyer GR, et al. (2021). Angelman syndrome phenotype with GABRG3. Ann Hum Genet, doi:10.1111/ahg.12449. [Cited by: 4]

Abbas NZ, Iyer GR, et al. (2020). Genotype-Phenotype correlation in pediatric neurology. Int J Health Clin Res, 3(5):67–73. [Cited by: 2]

Iyer G, et al. (2020). COVID-19 therapy driven by pharmacogenomics. AIJR Preprints. [Cited by: 7]

Iyer GR, et al. (2020). Host gene variants and COVID-19 progression. Front Genet, 11:861. [Cited by: 10]

Conclusion

Dr. Gayatri R. Iyer exemplifies the ethos of a best researcher through her unwavering commitment to bridging science and clinical application. Her pioneering work in low-cost diagnostic development for rare disorders, hands-on clinical counseling experience, interdisciplinary teaching, and highly cited publications affirm her exceptional contribution to medical genetics and public health. Her nomination for the Best Researcher Award is a recognition of her dedication, innovation, and leadership in translating genetic research into impactful health solutions.

Haochen Xu | Bioinformatics | Best Researcher Award

Published on by Computational Biologists

Mr.Haochen  Xu |  Bioinformatics | Best Researcher Award 

Graduate student at   Luxun Academy of Fine Arts,  China.

Mr. Haochen Xu is a graduate student in the Architectural Art and Design program at the esteemed Lu Xun Academy of Fine Arts. His academic journey is deeply rooted in the fusion of art, architecture, and psychology. Haochen’s academic focus centers around understanding how architectural environments influence human behavior, emphasizing a multi-disciplinary approach that reflects both creative expression and scientific inquiry.

Profile:

🎓 Academic Background:

Mr. Haochen Xu is currently pursuing his graduate studies in Architectural Art and Design at the Lu Xun Academy of Fine Arts, one of China’s most prestigious institutions for art and design education. His academic training emphasizes the integration of artistic creativity with architectural theory, offering a solid foundation in both visual aesthetics and spatial functionality. Through his coursework and research, Haochen has cultivated a deep understanding of human-centric design, with a particular focus on how multi-sensory experiences influence spatial perception and user behavior. His education has equipped him with the skills to think critically, design innovatively, and approach architecture as both an art form and a scientific discipline.

🧠 Research Focus and Innovation:

Haochen’s research lies at the intersection of spatial perception and multi-sensory design, with a keen interest in how people emotionally and psychologically respond to built environments. His innovative work explores how visual, auditory, tactile, and olfactory elements can be harmoniously integrated into architectural spaces to shape human behavior and deepen emotional engagement. By challenging conventional design norms, Haochen strives to make architectural experiences more immersive, empathetic, and human-centric.

🏆 Awards and Recognition:

In recognition of his groundbreaking research and creative design thinking, Haochen has received international accolades, including the prestigious 2025 Muse Platinum Award in the United States and the 2024–2025 A’Design Bronze Award. These honors validate his contribution to advancing architectural design with a focus on emotional resonance and sensory immersion.

🔬 Current Endeavors:

Haochen has completed two research projects and is currently involved in a third, furthering his exploration of multi-sensory architectural design. Although he is in the formative stages of his academic career, his progress demonstrates clear potential for long-term impact in his field.

📚 Publications:

  1. Xu, H., Zhao, J., Jin, C., Zhu, N., & Chai, Y. (2025). Research on the Multi-Sensory Experience Design of Interior Spaces from the Perspective of Spatial Perception: A Case Study of Suzhou Coffee Roasting Factory. Buildings, 15(8), Article 1393.

  2. Zhu, N., Xu, H., Zhang, X., & Chen, L. (2025). A Study on the Influence of Rural Tourism’s Perceived Destination Restorative Qualities on Loyalty Based on SOR Model. Frontiers in Psychology, 16, Article 1529686.